Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol
2002; 39: 1890–1900.
Oyen, N, Poulsen, G, Boyd, HA, et al. Recurrence of congenital heart defects in families. Circulation
2009; 120: 295–301.
Hartman, RJ, Rasmussen, SA, Botto, LD, et al. The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol
2011; 32: 1147–1157.
Rowland, TW, Hubbell, JP, Nadas, AS. Congenital heart disease in infants of diabetic mothers. J Pediatr
1973; 83: 815–820.
Miller, A, Riehle-Colarusso, T, Siffel, C, et al. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet Part A
2011; 155: 2137–2145.
Olshan, AF, Schnitzer, PG, Baird, PA. Paternal age and the risk of congenital heart defects. Teratology
1994; 50: 80–84.
Mills, JL, Troendle, J, Conley, MR, et al. Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr
2010; 91: 1543–1549.
van der Linde, D, Konings, EM, Slager, MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol
2011; 58: 2241–2247.
Restivo, A, Piacentini, G, Placidi, S, et al. Cardiac outflow tract: a review of some embryogenetic aspects of the conotruncal region of the heart. Anat Rec A Discov Mol Cell Evol Biol
2006; 288: 936–943.
Adams, MM, Mulinare, J, Dooley, K. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol
1989; 14: 432–442.
Johnson, MC, Hing, A, Wood, MK, et al. Chromosomal anomalies in congenital heart disease. Am J Med Genet
1997; 70: 292–298.
O’Malley, CD, Shaw, GM, Wasserman, CR, et al. Epidemiologic characteristics of conotruncal heart defects in California, 1987–1988. Teratology
1996; 53: 374–377.
Francannet, C, Lancaster, PA, Pradat, P, et al. The epidemiology of three serious cardiac defects. A joint study between five centres. Eur J Epidemiol
1993; 9: 607–616.
Lary, JM, Paulozzi, LJ. Sex differences in the prevalence of human birth defects: a population-based study. Teratology
2001; 64: 237–251.
Grech, V. Diagnostic and interventional trends in tetralogy of Fallot and trans-position of the great arteries in a population-based study. Pediatr Cardiol
2000; 21: 368–373.
Loffredo, CA, Wilson, PD, Ferencz, C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology
2001; 64: 98–106.
Ferencz, C, Rubin, JD, McCarter, RJ, et al. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology
1990; 141: 319–326.
Sayasathid, J, Sukonpan, K, Somboonna, N. Epidemiology and etiology of congenital heart diseases. In: Syamasundar Rao P, ed. Congenital Heart Disease – Selected Aspects. InTech, Rijeka, Croatia, 2012: 47–84.
Dolk, H, Loane, M, EUROCAT Steering Committee. Congenital heart defects in Europe prevalence and perinatal mortality, 2000 to 2005. Circulation 2011: 841–849.
Wu, MH, Chen, HC, Lu, CW, et al. Prevalence of congenital heart disease at live birth in Taiwan. J Pediatr
2010; 156: 782–785.
Reller, MD, Stricklland, MJ, Richle-Colarusso, T, et al. Prevalence of congenital heart defect in metropolitan Atlanta, 1998–2005. J Pediatr
2008; 153: 803–813.
Jaber, L, Merlob, P, Shohat, M. High incidence of central nervous system malformations associated with marked parental consanguinity in an Israeli Arab community. Biomed Pharmacother
1994; 48: 351–354.
Dolk, H, Loane, M, Game, E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol
2010; 686: 349–364.
Bjornard, K, Riehle-Colarusso, T, Gilboa, SM, et al. Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol
2013; 97: 87–94.
Øyen, N, Poulsen, G, Boyd, HA, et al. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J
2009; 157: 467–473.e1.
Leirgul, E, Fomina, T, Brodwall, K, et al. Birth prevalence of congenital heart defects in Norway 1994-2009 – a nationwide study. Am Heart J
2014; 168: 956–964.
Jaber, L, Halpern, GJ, Shohat, M. The impact of consanguinity worldwide. Community Genet
1998; 1: 12–17.
Kulkarni, ML, Kurian, M. Consanguinity and its effect on fetal growth and development: a south Indian study. J Med Genet
1990; 27: 348–352.
Jaber, L, Merlob, P, Bu, X, Rotter, JI, Shohat, M. Marked parental consanguinity as a cause for increased major malformations in an Israeli Arab community. Am J Med Genet
1992; 44: 1–6.
Grjibovski, AM, Magnus, P, Stoltenberg, C. Decrease in consanguinity among parents of children born in Norway to women of Pakistani origin: a registry-based study. Scand J Public Health
2009; 37: 232–238.
El-Shafei, A, Rao, PSS, Sandhu, AK. Congenital malformations and consanguinity. Aust NZ J Obstet Gynaecol
1986; 26: 168–172.
Magnus, P, Berg, K, Bjerkedal, T. Association of parental consanguinity with decreased birth weight and increased rate of early death and congenital malformations. Clin Genet
1985; 28: 335–342.
Fung, A, Manlhiot, C, Naik, S, et al. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc
2013; 2: e000064.
Zhang, L, Zhang, XH, Ren, MH, et al. Chromosome abnormalities and congenital heart diseases: a retrospective on 49 cases. Sichuan Da Xue Xue Bao Yi Xue Ban
2010; 41: 312–315.
Harris, JA, Francannet, C, Pradat, P, et al. The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations. Pediatr Cardiol
2003; 24: 222–235.
Garne, E, Nielsen, G, Hansen, OK, et al. Tetralogy of Fallot. A population-based study of epidemiology, associated malformations and survival in western Denmark 1984-1992. Scand Cardiovasc J
1999; 33: 45–48.
Beauchesne, LM, Warnes, CA, Connolly, HM, et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol
2005; 45: 595–598.
Boudjemline, Y, Fermont, L, Le Bidois, J, et al. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr
2001; 138: 520–524.
Cuneo, BF. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr
2001; 13: 465–472.
Driscoll, DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med
2001; 3: 14–18.
Nora, JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol
1994; 23: 1468–1471.
Csáky-Szunyogh, M, Vereczkey, A, Kósa, Z, et al. Risk and protective factors in the origin of conotruncal defects of heart – a population-based case–control study. Am J Med Genet A
2013; 161A: 2444–2452.